Vascular remodeling and TSLP/angiogenin overexpression in severe mixed asthma.

IF 5.8 2区 医学 Q1 Medicine Respiratory Research Pub Date : 2025-02-28 DOI:10.1186/s12931-025-03133-9
Francesca Bertolini, Vitina M A Carriero, Elisa Arrigo, Giuseppe Guida, Stefano Levra, Stefano Pizzimenti, Mirella Profita, Isabella Gnemmi, Antonino Di Stefano, Fabio L M Ricciardolo
{"title":"Vascular remodeling and TSLP/angiogenin overexpression in severe mixed asthma.","authors":"Francesca Bertolini, Vitina M A Carriero, Elisa Arrigo, Giuseppe Guida, Stefano Levra, Stefano Pizzimenti, Mirella Profita, Isabella Gnemmi, Antonino Di Stefano, Fabio L M Ricciardolo","doi":"10.1186/s12931-025-03133-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Asthma with neutrophilic/mixed inflammation is a difficult-to-control clinical phenotype. Currently, vascular and matrix airway remodeling in asthma with neutrophilic/mixed inflammation is not well known. We aimed to evaluate the differences in vascular/smooth muscle/matrix related asthma remodeling in eosinophilic (EOS) and mixed/neutrophilic (MIXED) bronchial phenotypes in relation to asthma severity and exacerbation frequency.</p><p><strong>Methods: </strong>In this cross-sectional study, α-SMA<sup>+</sup> cells (100µM beneath the basement membrane [BM]), BM thickness, vascular remodeling-related biomarkers (angiogenin, vascular endothelial growth factor [VEGF], CD31 and Protease-activated receptor 2 [PAR2]), alarmins (TSLP and Interleukin (IL)-33) were evaluated in bronchial sections from 40 mild-to-severe asthmatics (EOS: N = 19 and mixed/neutrophilic: N = 19/2) and 7 control subjects (CTRL).</p><p><strong>Results: </strong>The number of CD31<sup>+</sup> and angiogenin<sup>+</sup> cells was higher in MIXED than in EOS asthmatics (p < 0.05). In severe MIXED CD31<sup>+</sup>, TSLP<sup>+</sup>, α-SMA<sup>+</sup>, and angiogenin<sup>+</sup> cells increased compared to mild MIXED/EOS or severe EOS (p < 0.05), but BM thickness was higher in severe vs. mild EOS (p < 0.05). MIXED frequent exacerbators had higher numbers of CD31<sup>+</sup> and TSLP<sup>+</sup> cells, whereas MIXED non-exacerbators had increased PAR2<sup>+</sup> cells. CD31<sup>+</sup> cells correlated with impairment of pulmonary functions, number of exacerbations, ICS dose, bronchial neutrophils, angiogenin, α-SMA, TSLP and IL-33 (p < 0.05). Finally, CD31 > 97.17 cells/mm<sup>2</sup>, angiogenin > 35.36 cells/mm<sup>2</sup>, and functional parameters such as FEV<sub>1</sub>, FEV<sub>1</sub>/FVC, TLC and FRC (%pred.) were found to be predictors of severe MIXED asthma.</p><p><strong>Conclusion: </strong>The severe or frequent exacerbator asthmatics with bronchial mixed inflammatory profile are characterized by increased number of vessels and overexpression of TSLP and angiogenin, suggesting a pathogenetic link between mixed eosinophilic and neutrophilic inflammation and vascular remodeling.</p>","PeriodicalId":49131,"journal":{"name":"Respiratory Research","volume":"26 1","pages":"78"},"PeriodicalIF":5.8000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11871842/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12931-025-03133-9","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Asthma with neutrophilic/mixed inflammation is a difficult-to-control clinical phenotype. Currently, vascular and matrix airway remodeling in asthma with neutrophilic/mixed inflammation is not well known. We aimed to evaluate the differences in vascular/smooth muscle/matrix related asthma remodeling in eosinophilic (EOS) and mixed/neutrophilic (MIXED) bronchial phenotypes in relation to asthma severity and exacerbation frequency.

Methods: In this cross-sectional study, α-SMA+ cells (100µM beneath the basement membrane [BM]), BM thickness, vascular remodeling-related biomarkers (angiogenin, vascular endothelial growth factor [VEGF], CD31 and Protease-activated receptor 2 [PAR2]), alarmins (TSLP and Interleukin (IL)-33) were evaluated in bronchial sections from 40 mild-to-severe asthmatics (EOS: N = 19 and mixed/neutrophilic: N = 19/2) and 7 control subjects (CTRL).

Results: The number of CD31+ and angiogenin+ cells was higher in MIXED than in EOS asthmatics (p < 0.05). In severe MIXED CD31+, TSLP+, α-SMA+, and angiogenin+ cells increased compared to mild MIXED/EOS or severe EOS (p < 0.05), but BM thickness was higher in severe vs. mild EOS (p < 0.05). MIXED frequent exacerbators had higher numbers of CD31+ and TSLP+ cells, whereas MIXED non-exacerbators had increased PAR2+ cells. CD31+ cells correlated with impairment of pulmonary functions, number of exacerbations, ICS dose, bronchial neutrophils, angiogenin, α-SMA, TSLP and IL-33 (p < 0.05). Finally, CD31 > 97.17 cells/mm2, angiogenin > 35.36 cells/mm2, and functional parameters such as FEV1, FEV1/FVC, TLC and FRC (%pred.) were found to be predictors of severe MIXED asthma.

Conclusion: The severe or frequent exacerbator asthmatics with bronchial mixed inflammatory profile are characterized by increased number of vessels and overexpression of TSLP and angiogenin, suggesting a pathogenetic link between mixed eosinophilic and neutrophilic inflammation and vascular remodeling.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
严重混合性哮喘的血管重塑和 TSLP/angiogenin 过度表达。
背景:哮喘伴中性粒细胞/混合性炎症是一种难以控制的临床表型。目前,血管和基质气道重塑在哮喘伴中性粒细胞/混合性炎症中的作用尚不清楚。我们的目的是评估嗜酸性(EOS)和混合/中性粒细胞(mixed)支气管表型中血管/平滑肌/基质相关哮喘重塑与哮喘严重程度和发作频率的差异。方法:在横断研究中,对40例中重度哮喘患者(EOS: N = 19,混合型/嗜中性粒细胞:N = 19/2)和7例对照组(CTRL)的支气管切片进行α-SMA+细胞(基底膜下100µM)、基底膜厚度、血管重构相关生物标志物(血管生成素、血管内皮生长因子[VEGF]、CD31和蛋白酶激活受体2 [PAR2])、报警因子(TSLP和白细胞介素(IL)-33)的检测。结果:MIXED哮喘组CD31+和血管生成素+细胞数量高于EOS哮喘组(p +、TSLP+、α-SMA+),血管生成素+细胞数量高于轻度MIXED/EOS或重度EOS哮喘组(p +和TSLP+),而非加重者的PAR2+细胞数量增加。CD31+细胞与肺功能损害、加重次数、ICS剂量、支气管中性粒细胞、血管生成素、α-SMA、TSLP和IL-33 (p 97.17 cells/mm2,血管生成素> 35.36 cells/mm2)以及功能参数如FEV1、FEV1/FVC、TLC和FRC (%pred)相关,被发现是严重混合性哮喘的预测因子。结论:重型或频繁加重性哮喘伴支气管混合性炎症表现为血管数量增加、TSLP和血管生成素过表达,提示混合性嗜酸性和嗜中性粒细胞炎症与血管重构之间存在病理联系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Respiratory Research
Respiratory Research RESPIRATORY SYSTEM-
CiteScore
9.70
自引率
1.70%
发文量
314
审稿时长
4-8 weeks
期刊介绍: Respiratory Research publishes high-quality clinical and basic research, review and commentary articles on all aspects of respiratory medicine and related diseases. As the leading fully open access journal in the field, Respiratory Research provides an essential resource for pulmonologists, allergists, immunologists and other physicians, researchers, healthcare workers and medical students with worldwide dissemination of articles resulting in high visibility and generating international discussion. Topics of specific interest include asthma, chronic obstructive pulmonary disease, cystic fibrosis, genetics, infectious diseases, interstitial lung diseases, lung development, lung tumors, occupational and environmental factors, pulmonary circulation, pulmonary pharmacology and therapeutics, respiratory immunology, respiratory physiology, and sleep-related respiratory problems.
期刊最新文献
Correction: Reference equations for pulmonary function testing in healthy Chinese children aged 4-18 years. Modulation of the NF-κB signaling pathway by the combined strategy of tocilizumab and dexamethasone for asthma therapy. GLCCI1 alleviates airway remodeling in asthmatic mice by inhibiting ZEB1-mediated epithelial-mesenchymal transition. Outcomes after biologic initiation among patients with severe asthma and normal lung function in the CHRONICLE study. Plasma extracellular vesicles-derived MicroRNAs as potential biomarkers in idiopathic pulmonary fibrosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1